Skip to main content

American Well Corp

corporate_fare Company Profile

American Well Corp

AMWL·NYSE·Technology·CIK 0001393584

Amwell is an enterprise platform and software company that digitally enables hybrid care. The company provides core technology and services to health providers, payers, and innovators to develop and distribute digital care programs under their own brands. Founded in 2006, Amwell’s platform supports care across in-person, virtual, and automated modalities. As of December 31, 2025, Amwell powers digital care programs for approximately 50 health plans, covering over 90 million lives, and approximately 80 of the nation's largest health systems. Since its inception, Amwell has powered more than 37.6 million virtual care visits for its clients, including over 4.5 million in the year ended December 31, 2025. The Amwell Platform, which consists of enterprise platform and software as a service solutions, enables hybrid care delivery. For health systems, the platform facilitates provider-to-provider virtual care for uses such as stroke and virtual nursing. Amwell’s suite of Carepoint devices enhances in-person care by converting existing equipment like televisions or iPads into digital access points, or through the use of Amwell Carepoint carts and peripherals. The Amwell Platform also extends care outside traditional settings, enabling on-demand and scheduled provider-to-patient care for urgent care, primary care, behavioral health, chronic disease management, and specialty follow-up care.

American Well Corp (NYSE:AMWL) is a publicly traded company in the Technology sector. Wiseek has independently scored 13 items for AMWL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-08, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for AMWL spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • VA Issues Letter of Intent to Deploy Amwell's Virtual Health Platform Enterprise-Wide
  • Amwell Raises 2026 Revenue Guidance to $200M–$205M, Narrows EBITDA Loss
  • Amwell Raises FY Guidance After Q2 Revenue Beat, Cost Cuts Narrow Loss
  • Amwell Q2 Revenue Drops 27% but Cost Cuts Narrow Loss; Cash Position Improves
  • Amwell Q2 Revenue Drops 27% but Cost Cuts Narrow Loss, Full-Year Outlook Raised

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$249.32M
Net Income
-$95.7M
Diluted EPS
-$5.96
Op. Cash Flow
-$65.95M
Free Cash Flow
-$65.97M
Operating Income
-$105.27M
Cash & Equivalents
$182.33M
Debt / Equity
0.00×
Net Margin
-38.4%
Shares Outstanding
16.43M sh
Source: 10-K · filed 2026-02-12 · accession 0001193125-26-048776
Browse all tickers starting with A →
$13.16 +0.16% today
52-week range · as of 2026-08-04 $3.71 – $13.45
Market cap
$221.11M
Volume
74.4K (0.7× avg)
3-mo avg 113.2K
Live data · 2026-09-14 01:23 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AMWL - Latest Insights

AMWL
Sep 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $13.22
Real-time Price: $13.16 info
Change: -$0.060 (-0.45%) info
Market Cap: $221.114M info
AMWL
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.04
Real-time Price: $13.16 info
Change: +$0.120 (+0.92%) info
Market Cap: $221.114M info
AMWL
Aug 04, 2026, 4:51 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.75
Real-time Price: $13.16 info
Change: +$1.41 (+12%) info
Market Cap: $221.114M info
AMWL
Aug 04, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.75
Real-time Price: $13.16 info
Change: +$1.41 (+12%) info
Market Cap: $221.114M info
AMWL
Aug 04, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.75
Real-time Price: $13.16 info
Change: +$1.41 (+12%) info
Market Cap: $221.114M info
AMWL
Jul 20, 2026, 5:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.35
Real-time Price: $13.16 info
Change: -$0.1885 (-1%) info
Market Cap: $221.114M info
AMWL
May 12, 2026, 8:53 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $8.06
Real-time Price: $13.16 info
Change: +$5.10 (+63%) info
Market Cap: $221.114M info
AMWL
May 12, 2026, 8:44 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.06
Real-time Price: $13.16 info
Change: +$5.10 (+63%) info
Market Cap: $221.114M info
AMWL
May 05, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.36
Real-time Price: $13.16 info
Change: +$5.80 (+79%) info
Market Cap: $221.114M info
AMWL
Feb 12, 2026, 4:17 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $4.65
Real-time Price: $13.16 info
Change: +$8.51 (+183%) info
Market Cap: $221.114M info
AMWL
Feb 12, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.36
Real-time Price: $13.16 info
Change: +$8.80 (+202%) info
Market Cap: $221.114M info
AMWL
Jan 08, 2026, 4:54 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.17
Real-time Price: $13.16 info
Change: +$7.99 (+155%) info
Market Cap: $221.114M info
AMWL
Jan 02, 2026, 5:19 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.85
Real-time Price: $13.16 info
Change: +$8.31 (+171%) info
Market Cap: $221.114M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets